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ORIGINAL ARTICLE
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ABSTRACT
Purpose: We sought to determine the prevalence of trachomatous inflammation – follicular (TF) in
children aged 1–9 years, and trachomatous trichiasis (TT) in those aged ≥15 years, in suspected
trachoma-endemic areas of Papua New Guinea (PNG).
Methods: We carried out six population-based prevalence surveys using the protocol developed
as part of the Global Trachoma Mapping Project.
Results: A total of 19,013 individuals were sampled for inclusion, with 15,641 (82.3%) consenting to
participate. Four evaluation units had prevalences of TF in children ≥10%, above which threshold
the World Health Organization (WHO) recommends mass drug administration (MDA) of azithromy-
cin for at least three years; Western Province (South Fly/Daru) 11.2% (95% confidence interval, CI,
6.9–17.0%), Southern Highlands (East) 12.2% (95% CI 9.6–15.0%), Southern Highlands (West) 11.7%
(95% CI 8.5–15.3%), and West New Britain 11.4% (95% CI 8.7–13.9%). TF prevalence was 5.0–9.9% in
Madang (9.4%, 95% CI 6.1–13.0%) and National Capital District (6.0%. 95% CI 3.2–9.1%) where
consideration of a single round of MDA is warranted. Cases of TT were not found outside West New
Britain, in which four cases were seen, generating an estimated population-level prevalence of TT in
adults of 0.10% (95% CI 0.00–0.40%) for West New Britain, below the WHO elimination threshold of
0.2% of those aged ≥15 years.
Conclusion: Trachoma is a public health issue in PNG. However, other than in West New Britain, there
are few data to support the idea that trachoma is a cause of blindness in PNG. Further research is
needed to understand the stimulus for the active trachoma phenotype in these populations.
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Introduction
Trachoma is an eye disease caused by infection with parti-
cular strains of the bacterium Chlamydia trachomatis. It is
the leading infectious cause of blindness worldwide, and is
found in the most isolated, rural areas of the developing
world.1 The bacterium is spread by direct close contact with
infected individuals, or indirectly, by contact with fomites
or with particular species of flies (Musca sorbens) that
passively transfer C. trachomatis on their bodies. The
early signs of infection (active trachoma) are most com-
monly seen in younger children, characterized by inflam-
matory thickening (trachomatous inflammation – intense,
TI) or sub-conjunctival follicles (trachomatous inflamma-
tion – follicular, TF) in the area of the upper tarsal
conjunctivae. Over many years, recurrent infections may
lead to scarring of the conjunctivae (trachomatous scar-
ring), with inward turning of the eyelashes so that they
touch the globe, known as trachomatous trichiasis (TT).
Persistent rubbing of these lashes can lead to opacification
of the cornea, and eventual corneal blindness.2
According to the World Health Organization (WHO),
51 countries are known or suspected to be endemic for
blinding trachoma, with the burden of disease concentrated
in Sub-SaharanAfrica.3 The disease is targeted byWHO for
elimination as a public health problem by the year 2020,
with control programs implementing the SAFE (Surgery,
Antibiotics, Facial cleanliness, Environmental improve-
ment) strategy in endemic areas.4,5
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Papua New Guinea (PNG) is a tropical island nation
located in the Western Pacific, directly north of
Australia. The country has 7.4 million inhabitants in
four major regions (Highlands, New Guinea Islands,
Momase/Northern, Southern) made up of 22 provinces,
and a total of 87 administrative districts (Figure 1).6
Communities are widely scattered and access to ser-
vices is often difficult, as >80% of the country’s popula-
tion lives in rural areas, only 3% of the roads are paved,
and many villages can only be reached on foot or by
air.7 PNG has high rates of visual impairment (29%)
and blindness (3.9–8.9%) in older adults; the most
recent epidemiological study conducted in urban and
rural populations of PNG’s capital (Port Moresby)
established that uncorrected refractive error and catar-
act were the two most common causes of visual impair-
ment in people aged 50 years and older.8,9
PNG has historically been noted as being trachoma
endemic,10 however current data are sparse. A study in
Madang Province published in 1982 described the results
of a 2-year survey of 6153 children in 30 community
schools, in which evidence of trachoma was found in
19.6% of children examined.11 In 1972, 4.6% of children
in a village on Manus Island (Manus Province) showed
signs of disease.12 A retrospective review of outpatient
notes at a Madang ophthalmology clinic found only 18
patients of 30,441 seen between 1980 and 1989 to have had
a presentation consistent with trachoma.13 A survey in
1979–1980 in four selected areas (Hanuabada in National
Capital District (NCD), Rigo district of Central province,
Rabaul township in East New Britain province and
Telefomin in Sandaun province) found very low levels
(0.3%, n = 3029) of visual impairment or blindness (visual
acuity <6/18) associated with trachoma, apart from in those
aged 60 years and older in Rabaul and Rigo, where 3.6%
and 6.1% of cases, respectively, were thought to be tra-
choma-related.10
Contemporary ophthalmologists regularly report seeing
signs of active trachoma in children in PNG, but rarely
report TT. The exception to this is in New Britain province,
where corrective trichiasis surgeries have been carried out
in recent years (unpublished data, Dr Jambi Garap, Dr
Apisai Kerek and Dr David Pahau). A similar pattern has
been seen in other Western Pacific countries such as the
Solomon Islands, Vanuatu, and Fiji, where recent surveys
have found a high prevalence of TF in the children, but
with little TT seen in adults (unpublished data, Mr O.
Sokana; personal correspondence, Ms F. Taleo).14
However, in neighboring Australia, trachoma is still a sig-
nificant cause of blindness in remote Indigenous commu-
nities. A 2008 population-based survey found trachoma in
60% of such communities, with TT present in 1.4% of
Indigenous adults examined.15,16
Until 2014, PNG had few or no current data to guide
trachoma control policy. In response to this, the National
Prevention of Blindness Committee, on behalf of the
Ministry of Health, commissioned trachoma rapid assess-
ments targeting suspected trachoma-endemic sites in six
provinces across the country (Central – NCD, Rigo;
Madang – Ramu; Morobe – Markham; East New Britain
– Rabaul; Southern Highlands – Mendi, Nipa; Western –
South Fly, Daru).17 An experienced, Global Trachoma
Mapping Project (GTMP) certified trachoma grader trai-
ner (OS) and a PNG ophthalmologist (DP) examined 823
children aged 1–9 years and 600 adults aged 15 years and
older in 22 sites, and found 93 cases of TF (11% of children
examined).17 In the sites in NCD, Madang, Markham,
Mendi, Nipa, and South Fly, >5% of the children examined
were found to have TF, and so a recommendation was
made for these areas to proceed to population-based pre-
valence surveys in the current study. West New Britain-
Talasea and Kandrian-Gloucester were also included due
to a recent history of trichiasis surgeries in these districts.
At the request of the National Prevention of Blindness
Committee, and on behalf of the Ministry of Health, we
planned to carry out seven cross-sectional trachoma pre-
valence surveys with the aim in each one of estimating the
prevalence of TF in children aged 1–9 years, and the pre-
valence of TT in adults aged 15 years and older. In addition,
we aimed to evaluate the association of water, sanitation
and hygiene (WASH) variables with trachoma in these
populations.
Materials and methods
The surveys were carried out in accordance with the
methodologies developed for the GTMP,18 with dis-
tricts grouped into evaluation units (EUs) of no more
than 200,000 total population. District grouping was
made respecting existing provincial administrative
boundaries (Figure 2).
Training
We conducted 5-day training for provincial Papua New
Guinean eye care workers. Prospective graders were
required to pass a class examination, and a field examina-
tion against a GTMP-certified grader trainer (OS). Data
recorders were required to pass a class examination, with
subsequent direct observation of fieldwork practice by
supervising ophthalmologists from the PNG Department
of Health. Participants were three ophthalmologists and 13
ophthalmic clinicians, refractionists and community health
care workers. All training was carried out in Port Moresby
on 5–9 October 2015.
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Ethical approval
The study protocol was approved by the Government of
PNG, National Department of Health Medical Research
Advisory Committee (approval 15.20) with the global pro-
ject methodologies approved by the London School of
Hygiene & Tropical Medicine (approvals 6319 and 8355).
Written consent (signature or finger print) was obtained
from household heads. Verbal consent to examination,
recorded on a custom-coded smartphone application, was
considered acceptable in a setting where literacy rates were
anticipated to be low. For those younger than 18 years,
consent was obtained from a parent or guardian.
Figure 1. Map of regions in Papua New Guinea.
Figure 2. Evaluation units of grouped districts, Global Trachoma Mapping Project, Papua New Guinea, 2015; Morobe (Markham,
Nawae, Huon), Southern Highlands (East; Mendi-Munihu, Imbonggu, Ialibu/Pangia), Southern Highlands (West; Nipa/Kutubu, Kagua/
Erave), West New Britain (Talasea, Kandrian-Gloucester), Madang (Madang, Middle Ramu, Usino Bundi), Western Province (South Fly,
Daru), National Capital District.
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Participants found to have active trachoma (TF and/or TI
in either eye) were provided with two tubes of tetracycline
eye ointment to complete a 6-week course. Participants
found to have TT were referred to the nearest eye health
facility for further assessment and management. Patient
confidentiality was maintained at all times, and data were
anonymized before analysis.
Field methods
The overall GTMP methodology is outlined elsewhere.18
Briefly, each survey team was made up of one grader, one
data recorder, and one driver or logistician. A local guide
was also recruited and acted as the interpreter in most
cases. The village elder (either a pastor, magistrate or a
counsellor) provided permission for the survey team to
enter the village, and supplied a village household census
list. Every household was allocated a number, from which
30 random numbers were drawn representing the 30
households selected for examination. At each sampled
household, the purpose of the survey was explained, with
information provided in local languages by the local guide/
interpreter. All occupants older than 1 year of age present
at the time of the survey were invited to participate. If a
household was unoccupied, the most immediate neighbor-
ing house was approached. If a sampled village was inac-
cessible or unsuitable due to bad roads, severe weather, or
migration, then the next-nearest village was sampled. Prior
to commencement, where possible, public announcements
were made on local radio, and written notices highlighting
the dates and purpose of the survey were displayed in
sampled villages. The ability to provide villages advance
notice was limited in some areas of South Fly, Southern
Highlands, and West New Britain, as many villages were
outside the reach of telecommunication, and access
required considerable lengthy travel by road, sea or river.
After informed consent was provided, graders examined
the eyelid margins, and conjunctival surface of the upper
eyelids under sunlight or good torch light with the aid of a
2.5× magnifying loop, and signs of trachoma were assessed
using the WHO simplified trachoma grading system.2 The
presence or absence of the clinical signs TT, TF, and TI
were called to the data recorder, who immediately recorded
findings electronically using a smartphone application
(LINKS, Task Force for Global Health, Decatur, GA,
USA). Alcohol hand gel was used by the grader between
patients to prevent cross-contamination. At each house-
hold, Global Positioning System coordinates were col-
lected. Data recorders also recorded data on WASH
access by direct observation at the household, and by
focused interview with the household head. Full details
are published elsewhere.18
Sample size
As described previously,18 each survey was designed to
estimate an expected 10% TF prevalence in 1–9-year-
olds with an absolute precision of 3% and an estimated
non-response rate of 20%. We therefore needed to
sample sufficient households in each EU, such that
1222 children aged 1–9 years would be resident in
them. Based on the most recent census data,6 it was
estimated that a mean of 1.51 children aged 1–9 years
would reside in each household, so it was estimated
that 45 children aged 1–9 years would be resident in the
30 households sampled in each village. Therefore, to
achieve the target sample size of 1222 children in each
EU, we estimated that 27 (1222/45 = 27.0) clusters were
needed per EU.
Data analysis
Descriptive data were produced using Microsoft Excel
2010. Prevalence and risk factor analyses were pro-
duced using R 3.0.2 (2013, R Foundation for
Statistical Computing, Vienna, Austria). The village
was considered the cluster unit for the purposes of
analysis. TF prevalence in children aged 1–9 years was
adjusted for age in 1-year age-bands using the latest
available census data.6 TT prevalence in those aged ≥15
years was adjusted for age and sex in 5-year age-bands.
Confidence intervals (CIs) were generated by boot-
strapping adjusted mean cluster-level outcome propor-
tions, and taking the 2.5th and 97.5th centiles of 10,000
resampled iterations. Exact binomial CIs were used to
produce an upper confidence limit for zero-count pre-
valence estimates. A multi-level mixed random effects
model was used to assess the independent association
of determinant factors, accounting for the clustered
survey design at both village and household level,
where possible. Factors were considered for the full
model if statistically significant on univariate analysis
(Wald’s test, p < 0.05), trialed with a stepwise inclusion
approach and retained if statistically significant (p <
0.05, likelihood ratio test). Sex was included in the
final model due to a priori assumptions.
Results
Six teams surveyed six EUs covering 162 villages over
13 districts from October to December 2015. The
seventh planned EU, covering Markham, Nawae and
Huon districts in Morobe Province, could not be com-
pleted in the required timeframe as a result of insecur-
ity following an outbreak of inter-tribal violence. As a
result, data from this EU are not available here.
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Interviews were conducted with the household
heads of 4180 sampled households, and 19,013 indi-
viduals were sampled from these households, includ-
ing 6555 children aged 1–9 years. Overall, 15,641
people (82.3% of residents living in the sampled
households) were present and consented to examina-
tion. The median age of those examined was 15 years
(range 1–97 years). Overall, 3174 household residents
(16.6%) were absent at the time of the survey, and
194 (1.0%) were present but did not consent to
examination. Of the 194 participants who did not
consent to examination, 102 (52.3%), were from the
Southern Highlands (East) EU. The breakdown of
these findings by EU is shown in Table 1.
Overall, there were almost equal proportions of
males (49.5%) and females (50.5%) sampled. In those
aged 15 years and older, 59.4% of those examined were
female, and in those aged 1–9 years, 46.7% of those
examined were female (Table 2).
Adjusted TF prevalences in children aged 1–9 years for
each EU are shown in Table 3. Four EUs had TF preva-
lences higher than 10%; Western Province (South Fly/
Daru) 11.2% (95% CI 6.9–17.0%), Southern Highlands
(East) 12.2% (95% CI 9.6–15.0%), Southern Highlands
(West) 11.7% (95% CI 8.5–15.3%) and West New Britain
11.4% (95%CI 8.7–13.9%). The remaining two EUs had TF
prevalences <10%; Madang 9.4% (95% CI 6.1–13.0%) and
NCD 6.0% (95% CI 3.2–9.1%).
Four cases of TT were identified across all surveys;
one male aged 60 years, and three females aged 53, 54
and 70 years. All TT cases identified were found in
West New Britain. The details of numbers examined
by EU, and overall adjusted TT prevalences in those
aged 15 years and older, are shown in Table 3.
WASH indicators
Of participating households in the EU in NCD
(PNG’s capital city), 99.9% of households used
improved drinking water sources (water that is likely
to be protected from outside contamination), and
75.6% had improved sanitation (a facility that hygie-
nically separates human excreta from human
contact).19 In contrast, the surveys of two EUs in
the Southern Highlands, West (Nipa/Kutubu,
Kagua/Erave districts), and East (Mendi-Munihu,
Imbonggu, and Ialibu/Pangia districts) revealed low
prevalences of improved sanitation in households in
the Southern Highlands; 1.1% (95% CI 0.4–1.6%) and
0.0% (95% CI 0.0–1.0%), respectively. Table 4 sum-
marizes key indicators on WASH variables assessed
for each EU.
Risk factors
The univariable and multivariable analyses for associa-
tions of TF in children aged 1–9 years (Table 5), showed
that the odds of having TF was strongly and indepen-
dently associated with younger age. Children aged 1–5
years had significantly greater odds of having TF than did
those aged 6–9 years (odds ratio, OR, 1.6, p < 0.0001).
Other associations were household use of an unimproved
washing water source (OR 2.0, p < 0.0001), and house-
hold use of an unimproved latrine (OR 1.5, p = 0.03).
Discussion
Trachoma remains endemic in PNG, with TF preva-
lences ranging from 6.0 to 12.2% in the six EUs sur-
veyed in the work described here. All six EUs surveyed
are eligible for implementation of the A, F and E
components of the SAFE strategy, with the four EUs
that had TF>10% (Western Province – South Fly/Daru,
Southern Highlands – West, Southern Highlands –
East, and West New Britain) requiring three mass
drug administration (MDA) rounds, and the other
two EUs with TF prevalence 5.0–9.9% (NCD and
Madang) requiring one round of MDA before impact
surveys are undertaken. Population-based TT surgery
services are not required since all EUs had TT preva-
lences in adults below the elimination threshold of
0.2%, although directed case-finding around the iden-
tified cases would be recommended. TF prevalence was
lowest in NCD (the country’s administrative capital;
6.4%). This is consistent with the generally higher living
standards in the capital city, with 99% of households
having improved drinking water sources and 75% of
households having improved sanitation. WASH access
was strikingly lower in all other areas surveyed.
Active trachoma most commonly occurs in children,
with the highest prevalence in children younger than 5
years.20–22 In this study, younger children were more likely
than their older peers to have active trachoma. This con-
trasts with findings in nearby Solomon Islands, Fiji, and
Vanuatu, where older children (8–9 years) are reportedly
more likely to have TF (unpublished data, Mr O. Sokana,
Dr C. Macleod; personal correspondence, Ms F. Taleo).
Possible reasons for, and the robustness of, this distinction
are presently unclear.
The prevalence of TT was zero in five EUs. In West
New Britain, four TT cases were found, giving an EU-
level TT prevalence of 0.1% in those aged 15 years and
older. This is notable because this was the province in
which local ophthalmologists report carrying out tri-
chiasis surgeries in recent years. All EUs surveyed had
TT prevalences in adults below the WHO 0.2%
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Table 1. Participation rates and sex distribution of individuals sampled by evaluation unit, Global Trachoma Mapping Project, Papua
New Guinea, 2015.
Individuals
Evaluation unit
Western
Province
(South Fly/Daru) Madang
Southern Highlands
(East)
National Capital
District
Southern Highlands
(West)
West New
Britain Total n (%)
Examined 1775 3768 2172 3233 2731 1962 15,641 (82.3)
Absent 20 887 336 511 1001 419 3174 (16.7)
Refused 1 75 - 14 102 2 194 (1.0)
Other - - - 3a 1b - 4 (0.02)
Total 1796 4730 2508 3761 3835 2383 19,013
Male 814 (45.3%) 2338 (49.4%) 1344 (53.6%) 1793 (47.7%) 1910 (49.8%) 1204 (50.5%) 9403 (49.5)
Female 982 (54.7%) 2392 (50.6%) 1164 (46.4%) 1968 (52.3%) 1925 (50.2%) 1179 (49.5%) 9610 (50.5)
aTwo crying, one difficult to examine.
bOne recently deceased.
Table 2. Demographics of individuals aged 1–9 years and ≥15 years, sampled in six evaluation units, Global Trachoma Mapping
Project, Papua New Guinea, 2015.
Children 1–9 years, n (%) Adults 15+ years, n (%)
Individuals Male Female Total children 1–9 years, n Male Female Total adults 15+ years, n Total individualsa, n
Examined 3,195 (53.3) 2,796 (46.7) 5991 3277 (40.7) 4782 (59.3) 8059 14,050
Absent 227 (52.1) 208 (47.8) 435 1592 (67.1) 780 (32.9) 2,372 2,807
Refused 79 (50.3) 78 (49.7) 157 9 (32.1) 19 (67.9) 28 185
Other 1 (50.0) 1 (50.0) 2 2 (100) 0 (0.0) 2 4
Total 3502 3083 6585 4880 5581 10,461 17,046
aIndividuals aged 1–9 years or ≥15 years.
Table 3. Adjusted prevalence of trachomatous inflammation – follicular (TF) in children aged 1–9 years and trachomatous trichiasis
(TT) in those aged ≥15 years in six evaluation units, Global Trachoma Mapping Project, Papua New Guinea, 2015.
Individuals
Age 1–9 years Age 15+ years</TSH
Evaluation unit Examined, n TF, n (%)
Adjusted prevalencea,
% (95% CI) Examined, n TT, n (%)
Adjusted prevalenceb
TT, % (95%CI)
Western Province (South Fly/Daru) 790 101 (12.8) 11.2 (6.9–17.0) 821 0 0.0 (0.0–0.2)
Madang 1033 127 (12.3) 9.4 (6.1–13.0) 2062 0 0.0 (0.0–0.2)
Southern Highlands (East) 1391 176 (12.7) 12.2 (9.6–15.0) 773 0 0.0 (0.0–0.2)
National Capital District (NCD) 888 55 (6.2) 6.0 (3.2–9.1) 1987 0 0.0 (0.0–0.2)
Southern Highlands (West) 859 112 (13.0) 11.7 (8.5–15.3) 1579 0 0.0 (0.0–0.2)
West New Britain 1000 128 (12.8) 11.4 (8.7–13.9) 837 4 (0.48) 0.1 (0.0–0.4)
Total 5961 699 (11.7) - 8059 4 (0.05) -
aAdjusted for age in 1-year age groups.
bAdjusted for sex and age in 5-year age groups.
TF, trachomatous inflammation – follicular; TT, trachomatous trichiasis; CI, confidence interval.
Table 4. Water, sanitation and hygiene (WASH) variables, Global Trachoma Mapping Project, Papua New Guinea, 2015.
Evaluation unit
Households,
n
Households using improved
source of water for washinga,
% (95% CI)
Households with source of water for
washing within 1 km (30 minutes round-
trip), % (95% CI)
Households having
improved sanitation
facilitiesb, % (95% CI)
National Capital District 522 99.7 (99.3–100.0) 93.1 (88.0–96.8) 75.6 (62.6–85.6)
Southern Highlands (West) 589 11.6 (2.5–20.6) 43.7 (30.4–54.9) 1.1 (0.4–1.6)
Southern Highlands (East) 722 4.6 (0.1–11.3) 93.7 (89.2–99.1) 0.0 (0.0–1.0)
Madang 597 43.0 (28.4–54.0) 59.8 (49.3–71.5) 13.3 (4.1–18.6)
West New Britain 536 17.6 (6.1–32.4) 76.4 (62.9–90.1) 35.0 (24.2–48.4)
Western Province (South Fly/Daru) 404 52.8 (33.7–73.0) 52.5 (33.5–67.3) 16.8 (5.0–33.1)
aWater that is likely to be protected from outside contamination.
bA facility that hygienically separates human excreta from human contact.19
CI, confidence interval.
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threshold for elimination. This is consistent with the
prevailing belief that trachoma is endemic in PNG, but
not a cause of blindness.10,11
Overall, our data are insufficient to make meaningful
generalizations about the significance of the high TF/
low TT situation in PNG. Other Western Pacific Island
countries have also reported similar findings (unpub-
lished data, Mr O. Sokana, Dr C. Macleod; personal
correspondence, Ms F. Taleo).14,23 Interestingly, in
Aboriginal communities in nearby Australia, blindness
from trachoma is still a public health issue.16 We could
hypothesize that different C. trachomatis strains from
the ones associated elsewhere with trachoma could be
found in the Pacific, perhaps with gene polymorphisms
(such as in the matrix metalloproteinases)24 that are
important to the scarring process. It could also be
hypothesized that the follicles seen in children here
are related to stimuli other than C. trachomatis, such
as exposure to smoke from cooking fires,25 for example;
a common occurrence in PNG. Alternatively, a PNG/
Pacific human genotype may exist that confers resis-
tance or limits expression of trachomatous scarring, or
protective geoclimatic factors may be present.26
Of note, PNG is highly endemic for yaws,27 a disease
of skin, bone, and cartilage targeted by WHO for era-
dication by the year 2020. Yaws is caused by a
spirochaete bacterium, Treponema pallidum pertenue,
which is sensitive to a single dose of azithromycin.
MDA with azithromycin can effectively treat both tra-
choma and yaws,28 as well as urogenital chlamydial
infections.29,30 This might alter the possible balance of
cost and benefits towards implementation of azithro-
mycin mass treatment.
Trachoma has been linked with low levels of
sanitation31 and we noted very low levels of sanitation
in all EUs other than NCD. Less than 0.1% of house-
holds in the Southern Highlands had improved sanita-
tion. The presence of TF in children was strongly
linked to household use of an unimproved washing
water source, and household use of an unimproved
latrine. There is an urgent need for the improvement
of sanitation across PNG generally. PNG was recently
listed in a global report as having the highest propor-
tion of people without access to safe water (60%).32 The
WASH data presented here reflect those of the WHO
and United Nations Children’s Fund (UNICEF) Joint
Monitoring Programme for Water Supply and
Sanitation, showing considerable disparities in access
between urban and rural populations, and poor access
overall.19 Access to improved sanitation should
decrease transmission of a range of pathogens, as well
as being a basic human right.
Table 5. Multi–level random effects logistic regression of factors against the outcome trachomatous inflammation – follicular (TF) in
children aged 1–9 years, Global Trachoma Mapping Project, Papua New Guinea, 2015.
Univariable Multivariable
n Odds ratio (95% CI) Odds ratio (95% CI)
Age, years
1–5 3611 1.6 (1.3–2.0) 1.6 (1.3–2.0)
6–9 2350 1 1
Sex
Male 3175 1 1
Female 2786 1.2 (0.9–1.5) 1.3 (0.9–1.6)
Number of children 1–9 years in household
1–3 4756 1 1
≥4 1205 1.3 (0.9–1.8) 1.3 (0.9–1.8)
Household source of water used for washing
Unimproveda 3881 2.3 (1.7–3.0) 2.0 (1.4–2.8)
Improvedb 2080 1 1
Time to washing water source
≥30 minutes 1416 1.6 (1.6–2.1) 1.3 (0.9–1.7)
All washing at source 229 1.1 (0.6–2.1) 1.8 (0.9–3.4)
<30 minutes 4316 1 1
Household latrine
Unimprovedc 4689 2.1 (1.5–3.0) 1.5 (1.0–2.1)
Improved 1272 1 1
Time to drinking water source
≥30 minutes 1677 1.4 (1.1–1.9) Not included in final model due to
<30 minutes 4284 1 collinearity with time to washing source
Household drinking source
Unimproveda 3481 2.0 (1.5–2.6) Not included in final model due to collinearity with household
Improvedb 2480 1 source of water for washing
aUnprotected spring or dug well, surface water, bottled water.
bPiped water into dwelling or yard/plot, public tap or standpipe, tubewell or borehole, protected dug well, protected spring, rainwater.
cPit latrine without slab/open pit, hanging toilet/hanging latrine, open defecation.
Odds ratios significant at 0.05 level are shown in bold.
CI, confidence interval.
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Half of all refusals to participate came from one EU, in
Southern Highlands (West). This was reportedly related to
fears of visiting teams and a superstition that the team’s
smartphones introduced satanic messages. We were also
later informed that false rumors had spread among com-
munity residents implying that our survey teams were in
some way anti-Christian. Whether the individuals exam-
ined in this EU were truly representative of the underlying
population is unclear, although those who refused only
accounted for 2.7% of the total number resident in this
EU. Fundamentalist Christian communities are common
in PNG, and there is a growing recognition of the impor-
tance of understanding the different frameworks people
use in explaining their world.33,34 The reluctance to parti-
cipate that we encountered could conceivably recur in
future survey efforts, and in any attempts to deliver com-
munity-based trachoma elimination interventions.
Spending more time in dialogue with communities will
be necessary to appropriately foster trust. As we were
unable to collect sufficient data from one EU, no informa-
tion about the prevalence of trachoma in Morobe was
available. Further data will be collected when doing so
becomes possible. PNG is a very challenging country in
which to conduct research, as internal travel is very difficult
and costly, there are high levels of violence, and very low
numbers of trained health professionals.35 Additionally,
during 2015 much of PNG was affected by a severe
drought, which had a major impact on water supply, and
forced migration in many parts of the country.36 In all
other instances where the survey team was unable to com-
plete data collection from a sampled village (due to villager
superstition of the survey team, tribal fighting, inaccessi-
bility due to weather or village migration due to drought),
alternative villages were sampled and surveyed.
PNG possesses rich cultural diversity, with hundreds
of ethnic groups, marked socio-cultural differences
between and within provinces, and more than 800
indigenous languages. There is no internal road struc-
ture in the country, and communities are often isolated
from their nearest neighbors. Despite this, the epide-
miology of trachoma that we documented in this study
appeared to be largely uniform, and supports the theory
that trachoma is non-blinding here. Based on WHO
guidelines, elimination of active trachoma here is
recommended through MDA of azithromycin. This
approach may also be beneficial in the control of
other endemic conditions in PNG. Given the potential
cost, and possibly marginal benefit, the decision on
whether to implement costly azithromycin MDA
rounds is not simple, although almost certainly neces-
sary in West New Britain.
Trachoma is endemic in PNG but appears to not
have the blinding effects seen in many other countries.
The significance of this is unclear, and more research is
urgently needed to guide national and global policy
makers.
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